64.81
price up icon1.60%   1.02
after-market Handel nachbörslich: 64.81
loading

Finanzdaten der Anaptysbio Inc-Aktie (ANAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
41.84%
108.25
76.32 22.26 27.77 30.02
Operating Expenses
0.64%
41.35
41.62 48.43 55.31 52.77
Benefits Costs and Expenses
4.33%
58.55
61.21 60.85 67.06 62.87
Costs And Expenses
4.33%
58.55
61.21 60.85 67.06 62.87
Operating Income/Loss
92.78%
66.90
34.70 -26.17 -27.54 -22.76
Nonoperating Income/Loss
12.17%
-17.21
-19.59 -12.42 -11.75 -10.09
Income/Loss From Continuing Operations Before Tax
228.82%
49.70
15.11 -38.59 -39.28 -32.85
Income Tax Expense/Benefit
0.081
- 0.039 0.044 -
Income/Loss From Continuing Operations After Tax
228.29%
49.61
15.11 -38.63 -39.33 -32.85
Net Income/Loss
228.29%
49.61
15.11 -38.63 -39.33 -32.85
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
101.17%
-0.327
27.83 28.81 30.64 28.89
Diluted Average Shares
101.13%
-0.327
29.02 28.81 30.64 28.89
Basic Earnings Per Share
214.81%
1.70
0.54 -1.34 -1.28 -1.14
Diluted Earnings Per Share
226.92%
1.70
0.52 -1.34 -1.28 -1.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):